Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

P04035 (HMDH_HUMAN) Homo sapiens (Human)

3-hydroxy-3-methylglutaryl-coenzyme A reductase UniProtKBInterProSTRINGInteractive Modelling

888 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3)

Available Structures

22 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH HMG AND COA Heteromer
439-865
COA;MAH;DTT;
Assess
Thermodynamic and structure guided design of statin hmg-coa reductase inhibitors Heteromer
441-862
8HI;
Assess
Thermodynamic and structure guided design of statin hmg-coa reductase inhibitors Heteromer
441-861
4HI;
Assess
COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH COMPACTIN (ALSO KNOWN AS MEVASTATI… Heteromer
441-861
114;ADP;
Assess
Thermodynamic and structure guided design of statin hmg-coa reductase inhibitors Heteromer
441-861
3HI;
Assess
Thermodynamic and structure guided design of statin hmg-coa reductase inhibitors Heteromer
441-861
9HI;
Assess
Thermodynamic and structure guided design of statin hmg-coa reductase inhibitors Heteromer
441-861
6HI;
Assess
Thermodynamic and structure guided design of statin hmg-coa reductase inhibitors Heteromer
441-860
SO4;5HI;
Assess
Substituted Pyrazoles as Hepatselective HMG-COA reductase inhibitors Heteromer
441-860
SO4;RIE;
Assess
COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH ATORVASTATIN Heteromer
442-861
ADP;117;
Assess
COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH ROSUVASTATIN (FORMALLY KNOWN AS ZD… Heteromer
442-860
ADP;FBI;
Assess
COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH SIMVASTATIN Heteromer
442-860
ADP;SIM;
Assess
Thermodynamic and structure guided design of statin hmg-coa reductase inhibitors Heteromer
444-861
882;
Assess
Design and Synthesis of Pyrrole-based, Hepatoselective HMG-CoA Reductase Inhibitors Heteromer
444-861
882;
Assess
COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH HMG, COA, AND NADP+ Heteromer
462-872
COA;MAH;NAP;
Assess
Design and synthesis of novel, conformationally restricted HMG-COA reductase inhibitorshomo-4-mer441-866
SO4;HR2;
Assess
Thermodynamic and structure guided design of statin hmg-coa reductase inhibitorshomo-4-mer441-865
SO4;7HI;
Assess
Design and synthesis of novel, conformationally restricted HMG-COA reductase inhibitorshomo-4-mer441-861
SO4;HR1;
Assess
Hepatoselectivity of Statins: Design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inh…homo-4-mer441-861
RID;
Assess
COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH CERIVASTATINhomo-4-mer442-861
ADP;116;
Assess
COMPLEX OF CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH HMG-COAhomo-4-mer453-866
HMG;
Assess
COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH FLUVASTATINhomo-4-mer462-862
115;ADP;
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
1hw8.1.Bmonomer0.88443-860
99.78
Assess
8djk.1.Amonomer0.702-275
Y01;97.18
Assess

4 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 21dq9.1.Cmonomer0.80460-813
99.75
Assess
Isoform 28djk.1.Amonomer0.712-275
Y01;97.18
Assess
Isoform 31dq9.1.Cmonomer0.88480-886
99.78
Assess
Isoform 38djk.1.Amonomer0.6922-295
Y01;97.18
Assess